EUVIMEDEUVIMED entdecken
Crossref

STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment

Feng Ao, Xi Li, Yan Tan, Zebo Jiang, Fan Yang, Jingpei Guo, Qiancheng Zhu, Zhongguo Chen, Bin Zhou, Ke Zhang, Dan Li

Journal of Controlled Release · 2024-05 · 369 · 296-308

DOI: 10.1016/j.jconrel.2024.01.048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-05. Verfasst von Feng Ao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China; Department of Nu…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Membrane Proteins, Hydrogels. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunosuppression caused by incomplete radiofrequency ablation (iRFA) is a crucial factor affecting the effectiveness of RFA for solid tumors. However, little is known about the changes iRFA induces in the tumor immune microenvironment (TIME) of hepatocellular carcinoma (HCC), the primary application area for RFA. In this study, we found iRFA promotes a suppressive TIME in residual HCC tumors, characterized by M2 macrophage polarization, inhibited antigen presentation by dendritic cells (DCs), and reduced infiltration of cytotoxic T lymphocytes (CTLs). Interestingly, the STING agonist MSA-2 was able to reorganize M2-like tumor-promoting macrophages into M1-like anti-tumor states and enhance antigen presentation by DCs. To optimize the therapeutic effect of MSA-2, we used a calcium ion (Ca2+) responsive sodium alginate (ALG) as a carrier, forming an injectable hydrogel named ALG@MSA-2. This hydrogel can change from liquid to gel, maintaining continuous drug release in situ. Our results suggested that ALG@MSA-2 effectively activated anti-tumor immunity, as manifested by increased M1-like macrophage polarization, enhanced antigen presentation by DCs, increased CTL infiltration, and inhibited residual tumor growth. ALG@MSA-2 also resulted in a complete regression of contralateral tumors and widespread liver metastases in vivo. In addition, the excellent biosafety of ALG@MSA-2 was also proved by blood biochemical analysis and body weight changes in mice. In summary, this study demonstrated that the immune cascade of ALG@MSA-2 mediated the STING pathway activation and promoted a favorable TIME which might provide novel insights for the RFA treatment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMembrane ProteinsHydrogelsRadiofrequency AblationAlginatesMice, Inbred C57BLAnimalsDendritic CellsCell Line, TumorMacrophagesTumor MicroenvironmentMiceMaleT-Lymphocytes, CytotoxicHumansSTING Protein

Stichwörter der Autor:innen

Hepatocellular carcinoma (HCC)HydrogelRadiofrequency ablation (RFA)Stimulator of the interferon genes (STING) agonistTumor immune microenvironment (TIME)

Substanzen

Membrane ProteinsHydrogelsAlginatesSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Center for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China; Department of Nuclear Medicine, the Fifth Affiliated Hospital, Sun Yat-sen University,…
  • Center for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China; Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affil…
  • Department of Nuclear Medicine, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China; Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-…
  • Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China.
  • Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China; Department of Pediatrics, the Fifth Affiliated Hosp…
  • Center for Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province 519000, China; Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, the…

Zitieren

APA

Ao, F., Li, X., Tan, Y., Jiang, Z., Yang, F., Guo, J., Zhu, Q., Chen, Z., Zhou, B., Zhang, K., & Li, D. (2024). STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment. Journal of Controlled Release, 369, 296-308. https://doi.org/10.1016/j.jconrel.2024.01.048

Vancouver

Ao F, Li X, Tan Y, Jiang Z, Yang F, Guo J, et al. STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment. Journal of Controlled Release. 2024;369:296-308. doi:10.1016/j.jconrel.2024.01.048

BibTeX
@article{Ao2024,
  author = {Ao, Feng and Li, Xi and Tan, Yan and Jiang, Zebo and Yang, Fan and Guo, Jingpei and Zhu, Qiancheng and Chen, Zhongguo and Zhou, Bin and Zhang, Ke and Li, Dan},
  title = {STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {369},
  pages = {296--308},
  doi = {10.1016/j.jconrel.2024.01.048}
}
Kostenlos starten →